Every Life is Precious
We at Globela have strengthened our organization to create high quality and affordable health care solutions and reach the most under-served sections of the society, across the Globe.
WHO-GMP, EU-GMP, ISO Certified Pharmaceutical Solutions for Global Markets
Manufactured with precision, delivered to 50+ countries
End-to-End Pharmaceutical Expertise
From Discovery to Delivery – Vertically Integrated Across The Pharma Value Chain
Who We Are
At Globela, we believe Every Life Is Precious — and that belief shapes every solution we create. Established in 2006, we are a WHO-GMP, EU-GMP, ISO certified, trusted pharmaceutical manufacturer offering end-to-end capabilities in R&D, APIs & Intermediates, Semi-Finished & Finished Dosages, CRAMS & CDMO. With specialized facilities for Oncology and Cephalosporins, DSIR-approved R&D units, and regulatory expertise across global markets, we serve over 50 countries with high-quality, affordable pharmaceutical solutions. From concept to commercial scale, our one-stop pharma excellence model ensures innovation, compliance, and reliability, making us the partner of choice for companies seeking quality, speed, and purpose in every formulation.
Global Presence
Leading the pharmaceutical revolution in 50+ nations across the globe with highly researched, affordable and accessible healthcare products.
Latest at Globela
Globela Group brings end-to end oncology expertise to your portfolio, powered by EU GMP-certified manufacturing, deep scientific capabilities, and a commitment to affordable care.
Empower Your Oncology Portfolio with Globela
Globela Group brings end-to-end oncology expertise to your portfolio, powered by EU GMP-certified manufacturing, deep scientific capabilities, and a commitment to affordable care. We offer a broad range of high-efficacy oral solid cytotoxic formulations, from generic firsts to differentiated innovations, crafted with precision and purpose. Our CDMO and CMO services support every stage of your journey, from development and tech transfer to regulatory submission and global distribution. With strong in-house R&D, scalable infrastructure, and compliance across global markets, Globela is your trusted partner in building oncology solutions that deliver both clinical value and commercial success. Let’s co-create a future where cancer care is not just advanced, but accessible.
Blogs
Explore more about healthcare, latest developments, industry trends, our stories and more.
Why Affordability and Effectiveness Matter in Antimalarial Medicines?
Malaria is a global health problem affecting millions of individuals each year. Do you know that, according to WHO, the World Health Organization, in the year 2023, there were a total of 263 million cases of malaria reported and a total of 597,000 deaths worldwide? Despite incredible progress in the pharma sector over the years, the disease continues to flourish, significantly in the world’s most vulnerable and underprivileged regions and ages. It includes sub-Saharan Africa, children under the age of five years, and pregnant women...
Why Bridging the Health Equity Gap Is the Most Significant Step Towards a Healthier World
In the present era, where everything is running so fast, the scenario of scientific breakthroughs and the sector of healthcare is advancing rapidly. Still one breakdown stays permanent, and that is the “health equity gap.” This significantly shows a huge difference between the population that has easy access to healthcare and other populations with no such privilege, which is a necessity. This article will help you to easily understand why bridging this gap is not just a need of the hour but also a very crucial step to achieve a truly healthy and happy world...
Natural Killer Cells: Guardians of the Innate Immune System and front player in Oncology
For ages, cancer has been one of the major and great threats to mankind that causes ill health or death, which requires various therapies and medications to survive and become healthy...
The Role of CDMOs in Accelerating Time-to-Market for Pharma Innovations
The pharma industry in the present era faces various challenges to develop new, effective, and useful treatments for a wide array of health conditions and ailments...
